Log in to save to my catalogue

Implementation of population-based newborn screening reveals low incidence of spinal muscular atroph...

Implementation of population-based newborn screening reveals low incidence of spinal muscular atroph...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2404371065

Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy

About this item

Full title

Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy

Publisher

New York: Nature Publishing Group US

Journal title

Genetics in medicine, 2020-08, Vol.22 (8), p.1296-1302

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Purpose
Spinal muscular atrophy (SMA) was added to the Recommended Uniform Screening Panel (RUSP) in July 2018, following FDA approval of the first effective SMA treatment, and demonstration of feasibility of high-throughput newborn screening using a primary molecular assay. SMA newborn screening was implemented in New York State (NYS) on 1 Octo...

Alternative Titles

Full title

Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2404371065

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2404371065

Other Identifiers

ISSN

1098-3600

E-ISSN

1530-0366

DOI

10.1038/s41436-020-0824-3

How to access this item